Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Electrochaea GmbH manages a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. There are currently 3 pending office actions within this portfolio. These actions are distributed among 3 distinct examiners, yet they are all contained within 1 distinct art unit. This suggests that while the company has multiple applications in the examination phase, they are all being reviewed within the same specialized technical group at the patent office. The busiest examiner, KEELING, ALEXANDER W, is responsible for 1 pending action.
The distribution of 3 pending office actions across 3 distinct examiners means that no single examiner is handling more than 1 action. However, the concentration in 1 distinct art unit implies a consistent technical focus for the company's current filings. Practitioners should note that while they must navigate the individual styles of 3 distinct examiners, the overarching policy and technical standards of the 1 distinct art unit will likely apply to all pending office actions. This balance of multiple examiners within 1 unit is a key feature of the company's current prosecution landscape.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KEELING, ALEXANDER W | 1 | 55.9% | +38.1% |
| BREEN, KIMBERLY CATHERINE | 1 | 23.8% | +56.9% |
| EDWARDS, JESSICA FAYE | 1 | 39.1% | +46.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17904119 | BIOCATALYST ADAPTATION AS LOAD FOLLOWING SOLUTION | BREEN, KIMBERLY CATHERINE | 29d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17289377 | METHOD TO USE INDUSTRIAL CO2 CONTAINING GAS FOR THE PRODUCTION OF A METHANE ENRICHED GAS COMPOSITION | EDWARDS, JESSICA FAYE | 119d overdue |
| 17904119 | BIOCATALYST ADAPTATION AS LOAD FOLLOWING SOLUTION | BREEN, KIMBERLY CATHERINE | 29d |
| 18282443 | MEC SYSTEM | KEELING, ALEXANDER W | — |
| Art Unit | Apps |
|---|---|
| 1657 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18282443 | MEC SYSTEM | KEELING, ALEXANDER W | — | §103 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 17904119 | BIOCATALYST ADAPTATION AS LOAD FOLLOWING SOLUTION | BREEN, KIMBERLY CATHERINE | 1657 | §103 | Final Rejection | 29d | Pending | Aug 12, 2022 |
| 17289377 | METHOD TO USE INDUSTRIAL CO2 CONTAINING GAS FOR THE PRODUCTION OF A METHANE ENRICHED GAS COMPOSITION | EDWARDS, JESSICA FAYE | 1657 | §103 | Final Rejection | 119d overdue | Pending | Apr 28, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial